SEC Form 4 · accession 0001363763-15-000003
RespireRx Pharmaceuticals Inc. · RSPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert N Weingarten
Officer — VP and CFO · Director
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 4:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000849636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Options (to purchase shares of Common Stock)F1 | $0.025 | Jun 30, 2015 | A | 15,000,000 | A | — | Jun 30, 2022 | Common Stock | 15,000,000 | 15,000,000 | D |
| Common Stock Options (to purchase shares of Common Stock)F2 | $0.05 | holding | — | — | — | — | Jul 17, 2019 | Common Stock | 5,000,000 | 5,000,000 | D |
Explanation of responses
- F1These Common Stock Options vest in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015.
- F2These Common Stock Options vested in three equal installments on July 17, 2014, September 30, 2014 and December 31, 2014, and are all currently vested and exercisable.